AEVI-007 is a human monoclonal antibody that functions by affecting human interleukin (IL)-18. Interleukins are naturally occurring proteins that handle communication between cells, regulate cell growth, and manage differentiation to other cells in your body, and cell movement. Generally, levels of IL-18 are increased in patients with multiple myeloma and is associated with decreased survival of patients.
AEVI-007,in the treatment of relapsed or refractory multiple myeloma.
OPEN TO ACCRUAL